Teladoc expands services to offer obesity drug prescriptions

Teladoc Health Inc. is expanding its telehealth services to include prescribing obesity drugs such as Novo Nordisk's Wegovy, in the latest sign of growing interest in a multi-billion-dollar market, Reuters reports. Teladoc was so far providing doctor-based services to diabetes and hypertension patients through Livongo, the chronic care platform it acquired in 2020, but will now cater to a large market with new diabetes and weight loss medications as well.